Form 4: United Therapeutics Director Judy D. Olian Sells 1,750 Shares

Judy D. Olian, a director of United Therapeutics Corp, sold 1,750 shares of common stock at a price of $412.48 on November 11, 2024.

Summary

• On November 11, 2024, Judy D. Olian, a director of United Therapeutics Corp, sold 1,750 shares of common stock.
• The transaction was executed at a price of $412.48 per share.
• Following the transaction, Ms. Olian directly owns 5,655 shares of United Therapeutics Corp.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale by a company director, which is neither inherently positive nor negative. The sentiment is neutral.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like directors and officers, trade their company's stock. These filings provide transparency into insider transactions, which can be closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The sale of shares by a director could be perceived as a negative signal by some shareholders, although it may not necessarily reflect a negative outlook on the company's future.

Key Dates